RYLD vs XBI
Global X Russell 2000 Covered Call ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.60% for RYLD.
- • RYLD pays a higher dividend yield (6.81%).
Side-by-side metrics
| Metric | RYLD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.60% | 0.35% |
Dividend yield Trailing 12-month yield. | 6.81% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $1.36B | $10.73B |
YTD return | 10.76% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.54 | 1.10 |
P/E ratio | 18.65 | — |
Last price | $16.05 | $164.01 |
Inception | — | — |
Issuer | Global X | State Street |
RYLD top holdings
| RSSL | Global X Russell 2000 ETF | 102.91% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About RYLD
RYLD (Global X Russell 2000 Covered Call ETF) is Russell 2000 covered call strategy for income. Managed by Global X, the fund carries $1.4B in assets under management, an expense ratio of 0.60%, a dividend yield of 6.81%. Its largest holding is Global X Russell 2000 ETF (RSSL), which represents 102.9% of the portfolio. Real Estate is the fund's largest sector exposure at 6.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.